$ImmPACT Bio Announces FDA Clearance of IND Application for Bispecific CD19/CD20 CAR T Therapy IMPT-514 for the Treatment of Refractory Systemic Lupus Erythematosus$

Arati Desai 8/16/23 Arati Desai 8/16/23

ImmPACT Bio Announces FDA Clearance of IND Application for Bispecific CD19/CD20 CAR T Therapy IMPT-514 for the Treatment of Refractory Systemic Lupus Erythematosus

Arati Desai 8/10/23 Arati Desai 8/10/23

GEN: Top 10 U.S. Biopharma Clusters

Arati Desai 8/9/23 Arati Desai 8/9/23

Phase 1 clinical trial underway to test City of Hope-developed cancer treatment

Arati Desai 8/3/23 Arati Desai 8/3/23

Reflections and Takeaways from our Second Annual Greater Los Angeles Life Science Forum

Arati Desai 8/2/23 Arati Desai 8/2/23

Reed Jobs, son of Steve Jobs, takes the wraps off a $200 million venture fund that will back new cancer treatments

Arati Desai 8/2/23 Arati Desai 8/2/23

Biocom California Appoints Dan Gober as Executive Director of its Los Angeles Office

Arati Desai 8/1/23 Arati Desai 8/1/23

Life science entrepreneur Leen Kawas’s tips for what it takes for startups to thrive in 2023

Arati Desai 8/1/23 Arati Desai 8/1/23

Construction underway for Harbor-UCLA Medical Center's new clinic building

Arati Desai 7/31/23 Arati Desai 7/31/23

ARPA-H launches program for more precise cancer tumor removal

Arati Desai 7/31/23 Arati Desai 7/31/23

Will Irvine become the nation’s next healthcare hub?